Your browser doesn't support javascript.
Vaccine Inoculation Route Modulates Early Immunity and Consequently Antigen-Specific Immune Response.
Rosenbaum, Pierre; Tchitchek, Nicolas; Joly, Candie; Rodriguez Pozo, André; Stimmer, Lev; Langlois, Sébastien; Hocini, Hakim; Gosse, Leslie; Pejoski, David; Cosma, Antonio; Beignon, Anne-Sophie; Dereuddre-Bosquet, Nathalie; Levy, Yves; Le Grand, Roger; Martinon, Frédéric.
  • Rosenbaum P; UMR1184 IMVA-HB, IDMIT Department, Université Paris-Saclay - INSERM U1184 - CEA, Fontenay-aux-Roses, France.
  • Tchitchek N; Vaccine Research Institute, Henri Mondor Hospital, Créteil, France.
  • Joly C; UMR1184 IMVA-HB, IDMIT Department, Université Paris-Saclay - INSERM U1184 - CEA, Fontenay-aux-Roses, France.
  • Rodriguez Pozo A; Vaccine Research Institute, Henri Mondor Hospital, Créteil, France.
  • Stimmer L; UMR1184 IMVA-HB, IDMIT Department, Université Paris-Saclay - INSERM U1184 - CEA, Fontenay-aux-Roses, France.
  • Langlois S; Vaccine Research Institute, Henri Mondor Hospital, Créteil, France.
  • Hocini H; UMR1184 IMVA-HB, IDMIT Department, Université Paris-Saclay - INSERM U1184 - CEA, Fontenay-aux-Roses, France.
  • Gosse L; Vaccine Research Institute, Henri Mondor Hospital, Créteil, France.
  • Pejoski D; INSERM, U1169, Kremlin-Bicêtre, France.
  • Cosma A; CEA - INSERM, MIRCen, UMS27, Fontenay-aux-Roses, France.
  • Beignon AS; UMR1184 IMVA-HB, IDMIT Department, Université Paris-Saclay - INSERM U1184 - CEA, Fontenay-aux-Roses, France.
  • Dereuddre-Bosquet N; Vaccine Research Institute, Henri Mondor Hospital, Créteil, France.
  • Levy Y; Vaccine Research Institute, Henri Mondor Hospital, Créteil, France.
  • Le Grand R; INSERM, U955, Team 16, Clinical and Infectious Diseases Department, Hospital Henri Mondor, University of Paris East, Créteil, France.
  • Martinon F; UMR1184 IMVA-HB, IDMIT Department, Université Paris-Saclay - INSERM U1184 - CEA, Fontenay-aux-Roses, France.
Front Immunol ; 12: 645210, 2021.
Article in English | MEDLINE | ID: covidwho-1383856
ABSTRACT
Vaccination is one of the most efficient public healthcare measures to fight infectious diseases. Nevertheless, the immune mechanisms induced in vivo by vaccination are still unclear. The route of administration, an important vaccination parameter, can substantially modify the quality of the response. How the route of administration affects the generation and profile of immune responses is of major interest. Here, we aimed to extensively characterize the profiles of the innate and adaptive response to vaccination induced after intradermal, subcutaneous, or intramuscular administration with a modified vaccinia virus Ankara model vaccine in non-human primates. The adaptive response following subcutaneous immunization was clearly different from that following intradermal or intramuscular immunization. The subcutaneous route induced a higher level of neutralizing antibodies than the intradermal and intramuscular vaccination routes. In contrast, polyfunctional CD8+ T-cell responses were preferentially induced after intradermal or intramuscular injection. We observed the same dichotomy when analyzing the early molecular and cellular immune events, highlighting the recruitment of cell populations, such as CD8+ T lymphocytes and myeloid-derived suppressive cells, and the activation of key immunomodulatory gene pathways. These results demonstrate that the quality of the vaccine response induced by an attenuated vaccine is shaped by early and subtle modifications of the innate immune response. In this immunization context, the route of administration must be tailored to the desired type of protective immune response. This will be achieved through systems vaccinology and mathematical modeling, which will be critical for predicting the efficacy of the vaccination route for personalized medicine.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccinia / Vaccinia virus / Viral Vaccines / Vaccination / CD8-Positive T-Lymphocytes / Antibodies, Neutralizing / Myeloid-Derived Suppressor Cells / Antibodies, Viral Type of study: Prognostic study Topics: Vaccines Limits: Animals Language: English Journal: Front Immunol Year: 2021 Document Type: Article Affiliation country: FIMMU.2021.645210

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Vaccinia / Vaccinia virus / Viral Vaccines / Vaccination / CD8-Positive T-Lymphocytes / Antibodies, Neutralizing / Myeloid-Derived Suppressor Cells / Antibodies, Viral Type of study: Prognostic study Topics: Vaccines Limits: Animals Language: English Journal: Front Immunol Year: 2021 Document Type: Article Affiliation country: FIMMU.2021.645210